comprehensive -WSS

comprehensive

author：focus 2025-10-01 21:36:23 - browse：154

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Special counsel alerts court to Trump’s social media post

hotspot

knowledge

WSS

Climate activists disrupt London Pride march to protest corporate sponsorship

Traditional Chinese medicine benefits explored in new JAMA study

Cassava reveals details — and problems — with Alzheimer's study

Eat, drink, but be wary — 4 foods that interact with medications

Medical mystery: When an infection after surgery isn’t what it seems

Calls for Trump's election interference trial to be televised part of long debate

leisure time

comprehensive

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Medical mystery: When an infection after surgery isn’t what it seems

Jerome Adams on the need for new antivirals for Covid

Biden's order seeks to regulate AI risk without stifling innovation

Moonlake's readout produced a cash windfall. Risks remain

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

BioMarin wins approval for gene therapy to treat hemophilia A

Slain Parkland victim's father speaks out following reenactment

Novavax promises a turnaround & Lilly roils the obesity market

Eli Lilly to pay $200M for Beam’s stake in gene

focus

Telehealth options flood the market as retailers push virtual care

Pediatricians' group reaffirms support for gender

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

FDA has safety concerns on CRISPR

Does Medicare's free annual wellness visit do any good?

leisure time

hotspot

knowledge

focus